Your session is about to expire
← Back to Search
Lithium aspartate 15mg a day for Parkinson's Disease
Study Summary
This trial is testing if low doses of lithium can help treat Parkinson's by engaging certain blood-based targets involved in the disease. Results will help researchers determine if lithium is worth further investigating, what dose is most effective, and in which patients it is most helpful.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 46 Patients • NCT00596622Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the study accept participants below the age of 30?
"This clinical trial specifies that study participants must be aged 45 to 80. In contrast, there are 29 medical studies for individuals below the age of majority and 489 trials recruiting persons over 65 years old."
Are there any remaining slots accessible to participants in this trial?
"According to the information on clinicaltrials.gov, recruitment for this study is not currently taking place. This trial was initially posted on October 17th 2019 and last updated September 30th 2022. Despite being inactive, there are still 495 other studies recruiting participants at present time."
Has the FDA endorsed a dosage of 15mg Lithium aspartate per day?
"Due to the limited information available of lithium aspartate 15mg a day, our team at Power has rated its safety a 1 out of 3. This is typical for Phase 1 trials which have minimal data on efficacy and security."
Am I eligible to participate in this trial?
"Eligibility requirements mandate that individuals with parkinson's disease between the ages of 45 and 80 may join. Aspiring participants must also meet other criteria, as 19 slots are available in total."
What is the current cap on participant enrollment for this experiment?
"This medical trial has reached the end of its recruitment period, having first been posted on October 17th 2019 and last updated September 30th 2022. However, presently there are 485 clinical trials recruiting patients with Parkinson's disease as well as 10 studies for Lithium Aspartate 15mg a day that require participants."
Share this study with friends
Copy Link
Messenger